These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36982322)

  • 21. Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress.
    Wei Q; Ren X; Jiang Y; Jin H; Liu N; Li J
    BMC Cardiovasc Disord; 2013 Mar; 13():13. PubMed ID: 23497312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advanced glycation end products (AGEs) and their soluble receptors (sRAGE) as early predictors of reno-vascular complications in patients with uncontrolled type 2 diabetes mellitus.
    Farhan SS; Hussain SA
    Diabetes Metab Syndr; 2019; 13(4):2457-2461. PubMed ID: 31405660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.
    Zhang MH; Feng L; Zhu MM; Gu JF; Jiang J; Cheng XD; Ding SM; Wu C; Jia XB
    J Ethnopharmacol; 2014; 151(1):591-600. PubMed ID: 24269777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes.
    Yamagishi S; Matsui T; Nakamura K
    Curr Drug Targets; 2007 Oct; 8(10):1138-43. PubMed ID: 17979674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
    Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
    Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RAGE-Aptamer Blocks the Development and Progression of Experimental Diabetic Nephropathy.
    Matsui T; Higashimoto Y; Nishino Y; Nakamura N; Fukami K; Yamagishi SI
    Diabetes; 2017 Jun; 66(6):1683-1695. PubMed ID: 28385802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal denervation reduces atrial remodeling in hypertensive rats with metabolic syndrome.
    Selejan SR; Linz D; Mauz M; Hohl M; Huynh AKD; Speer T; Wintrich J; Kazakov A; Werner C; Mahfoud F; Böhm M
    Basic Res Cardiol; 2022 Jul; 117(1):36. PubMed ID: 35834066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Profilin‑1 contributes to cardiac injury induced by advanced glycation end‑products in rats.
    Yang D; Liu W; Ma L; Wang Y; Ma J; Jiang M; Deng X; Huang F; Yang T; Chen M
    Mol Med Rep; 2017 Nov; 16(5):6634-6641. PubMed ID: 28901418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: myth or reality.
    Prasad K
    Int J Angiol; 2014 Mar; 23(1):11-6. PubMed ID: 24627612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Divergent Changes in Plasma AGEs and sRAGE Isoforms Following an Overnight Fast in T1DM.
    Miranda ER; Fuller KNZ; Perkins RK; Beisswenger PJ; Farabi SS; Quinn L; Haus JM
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30781793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells.
    Huang K; Huang J; Xie X; Wang S; Chen C; Shen X; Liu P; Huang H
    Free Radic Biol Med; 2013 Dec; 65():528-540. PubMed ID: 23891678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockade of RAGE in Zucker obese rats with experimental periodontitis.
    Grauballe MB; Østergaard JA; Schou S; Flyvbjerg A; Holmstrup P
    J Periodontal Res; 2017 Feb; 52(1):97-106. PubMed ID: 26971526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of the receptor for advanced glycation end products (RAGE) -374 T/A gene polymorphism and circulating soluble RAGE with nephropathy in type 1 diabetic patients.
    Abdel-Azeez HA; El-Okely AM
    Egypt J Immunol; 2009; 16(1):95-106. PubMed ID: 20726326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trans-resveratrol mitigates type 1 diabetes-induced oxidative DNA damage and accumulation of advanced glycation end products in glomeruli and tubules of rat kidneys.
    Al-Hussaini H; Kilarkaje N
    Toxicol Appl Pharmacol; 2018 Jan; 339():97-109. PubMed ID: 29229234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating Ligands of the Receptor for Advanced Glycation End Products and the Soluble Form of the Receptor Modulate Cardiovascular Cell Apoptosis in Diabetes.
    Tsoporis JN; Hatziagelaki E; Gupta S; Izhar S; Salpeas V; Tsiavou A; Rigopoulos AG; Triantafyllis AS; Marshall JC; Parker TG; Rizos IK
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33182705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of soybean isoflavones on Wnt/β-catenin and the TGF-β1 signaling pathway in renal tissue of type 2 diabetic rats.
    Liu CL; Yan L; Cai KR; Sun K; Qi Y; Han YL; Zhang XD; Sun XD
    J Biol Regul Homeost Agents; 2018; 32(3):455-464. PubMed ID: 29921370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inactivation of Wnt/β-catenin/renin angiotensin axis by tumor necrosis factor-alpha inhibitor, infliximab, ameliorates CKD induced in rats.
    Younis NN; Mohamed HE; Shaheen MA; Abdelghafour AM; Hammad SK
    Biochem Pharmacol; 2021 Mar; 185():114426. PubMed ID: 33482150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA aptamer raised against receptor for advanced glycation end products suppresses renal tubular damage and improves insulin resistance in diabetic mice.
    Sotokawauchi A; Matsui T; Higashimoto Y; Nishino Y; Koga Y; Yagi M; Yamagishi SI
    Diab Vasc Dis Res; 2021; 18(1):1479164121990533. PubMed ID: 33535822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liraglutide suppresses production of extracellular matrix proteins and ameliorates renal injury of diabetic nephropathy by enhancing Wnt/β-catenin signaling.
    Huang L; Lin T; Shi M; Chen X; Wu P
    Am J Physiol Renal Physiol; 2020 Sep; 319(3):F458-F468. PubMed ID: 32715762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Klotho Regulates Epithelial-to-Mesenchymal Transition In Vitro via Wnt/β-Catenin Pathway and Attenuates Chronic Allograft Dysfunction in a Rat Renal Transplant Model.
    Li X; Lu P; Shao XF; Jiang T; Liu F; Li G
    Ann Transplant; 2021 Mar; 26():e930066. PubMed ID: 33737505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.